Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-09-18 Sale | 2020-09-22 8:02 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $99.98 | $499,918 | 131,196 (Indirect Direct) | View |
2020-06-12 Sale | 2020-06-15 8:12 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $61.16 | $305,788 | 122,435 (Indirect Direct) | View |
2020-03-13 Sale | 2020-03-17 5:08 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $48.56 | $242,816 | 126,577 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-01 Disposition | 2024-07-01 4:38 pm | N/A 2032-01-26 | ALUMIS INC. | ALMS | Hardiman Roy C. Chief Business & Legal Officer | 681,633 | $0 | 681,633 (Direct) | View |
2024-07-01 Option Award | 2024-07-01 4:38 pm | N/A 2032-01-26 | ALUMIS INC. | ALMS | Hardiman Roy C. Chief Business & Legal Officer | 681,633 | $0 | 681,633 (Direct) | View |
Ownership | 2024-06-27 4:05 pm | N/A N/A | ALUMIS INC. | ALMS | Hardiman Roy C. Chief Business & Legal Officer | 0 | $0 | 681,633 (Direct) | View |
2020-09-28 Equity Swap | 2020-09-28 5:14 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 119,677 | $100 | 0 (Direct) | View |
2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 170,553 | $0 | 0 (Direct) | View |
2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,242 | $7.2671 | 131,196 (Direct) | View |
2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 131,196 (Direct) | View |
2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,758 | $4.7236 | 131,196 (Direct) | View |
2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 122,435 (Direct) | View |
2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 122,435 (Direct) | View |
2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 126,577 (Direct) | View |
2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 126,577 (Direct) | View |
2020-03-05 Option Award | 2020-03-05 5:27 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 55,000 | $0 | 55,000 (Direct) | View |
2019-12-30 Ownership | 2020-02-14 5:04 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 3,780 | $0 | 118,819 (Direct) | View |